Clinical Trial Update: An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®

View source ↗

Summary

An observational study validating a scoring system to quantify the therapeutic response to Norditropin in adults with growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency | Status: COMPLETED